Hyris bCUBE RT-qPCR Test
Hyris bCUBE, as a RT-qPCR-based device, it is unmatched for its high sensitivity, often detecting infection in asymptomatic carriers. Authorized by Health Canada for point-of-care (onsite) testing in September 2020, the bCUBE is the chosen testing device by leading Canadian businesses, organizations, and communities, including the Province of Manitoba.
Up to 16 samples
per testing cycle
Quick results
120 minutes per analysis
99% specificity
100% sensitivity
PCR tests are ideal for controlled environments
PCR rapid tests are ideal for controlled
environments where an outbreak will have severe
economic and/or health impacts. This includes sports
tournaments, mining operations and remote
communities.